Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1613
    -0.0070 (-0.60%)
     
  • GBP/USD

    1.2373
    -0.0066 (-0.53%)
     
  • Bitcoin GBP

    52,032.99
    +906.35 (+1.77%)
     
  • CMC Crypto 200

    1,381.29
    +68.67 (+5.23%)
     
  • S&P 500

    4,966.00
    -45.12 (-0.90%)
     
  • DOW

    37,934.64
    +159.26 (+0.42%)
     
  • CRUDE OIL

    83.41
    +0.68 (+0.82%)
     
  • GOLD FUTURES

    2,409.60
    +11.60 (+0.48%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Global Sterility Indicators Market to Reach $1.4 Billion by 2027

Abstract: - Global Sterility Indicators Market to Reach $1. 4 Billion by 2027. - Amid the COVID-19 crisis, the global market for Sterility Indicators estimated at US$727. 4 Million in the year 2020, is projected to reach a revised size of US$1.

New York, May 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Sterility Indicators Industry" - https://www.reportlinker.com/p06033009/?utm_source=GNW
4 Billion by 2027, growing at aCAGR of 9.5% over the period 2020-2027. Biological, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$776.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemical segment is readjusted to a revised 11% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $196.8 Million, While China is Forecast to Grow at 12.6% CAGR
- The Sterility Indicators market in the U.S. is estimated at US$196.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$285 Million by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

- Select Competitors (Total 40 Featured) -

  • 3m Company

  • Anderson Products, Inc

  • Cantel Medical Corporation

  • Cardinal Health

  • Getinge Ab

  • gke-GmbH

  • Hu-Friedy Mfg. Co., LLC

  • Matachana Group

  • Mesa Laboratories

  • PMS

  • Propper Manufacturing Co., Inc

  • Steris plc




Read the full report: https://www.reportlinker.com/p06033009/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Sterility
Indicators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Sterility Indicators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Sterility Indicators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Biological by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Biological by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Biological by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Chemical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Chemical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Chemical by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Clinical
Laboratories / Research Centers by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Clinical Laboratories /
Research Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Clinical Laboratories /
Research Centers by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Pharmaceutical
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Pharmaceutical Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Pharmaceutical
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Medical Device
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Medical Device Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Medical Device
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Heat by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Heat by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Heat by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Low Temperature
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Low Temperature by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Low Temperature by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Filtration by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Filtration by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Filtration by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Other
Sterilization Methods by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Other Sterilization Methods
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Other Sterilization
Methods by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Sterility Indicators by Type -
Biological and Chemical Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 39: USA 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 41: USA Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: USA Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 45: USA 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: Canada Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 48: Canada 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 50: Canada Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Canada Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 54: Canada 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

JAPAN
Table 55: Japan Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Japan Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 57: Japan 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 59: Japan Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: Japan Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 63: Japan 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

CHINA
Table 64: China Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: China Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 66: China 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 68: China Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 70: China Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: China Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 72: China 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

EUROPE
Table 73: Europe Current & Future Analysis for Sterility
Indicators by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 74: Europe Historic Review for Sterility Indicators by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Sterility Indicators
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: Europe Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 78: Europe 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 80: Europe Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: Europe Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 84: Europe 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

FRANCE
Table 85: France Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: France Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 87: France 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: France Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 91: France Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: France Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 93: France 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

GERMANY
Table 94: Germany Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Germany Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 96: Germany 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 98: Germany Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 100: Germany Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 101: Germany Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 102: Germany 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

ITALY
Table 103: Italy Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: Italy Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 105: Italy 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 107: Italy Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 109: Italy Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: Italy Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 111: Italy 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 112: UK Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Sterility Indicators by Type -
Biological and Chemical Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 114: UK 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027

Table 115: UK Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 116: UK Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 117: UK 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 118: UK Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: UK Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 120: UK 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027

SPAIN
Table 121: Spain Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 122: Spain Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 123: Spain 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027

Table 124: Spain Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 125: Spain Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 126: Spain 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027

Table 127: Spain Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033009/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001